| Stage | BRK-B | % of rev | SKWD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $490M | 100.00% | BRK-B ×207.97 |
| Gross profit | $55.9B | 54.87% | $485M | 99.07% | SKWD +44.2pp |
| Operating income | $17.1B | 16.77% | $72M | 14.78% | BRK-B +2.0pp |
| Pre-tax income | $31.8B | 31.25% | $64M | 12.98% | BRK-B +18.3pp |
| Net income | $25.8B | 25.31% | $49M | 10.02% | BRK-B +15.3pp |
| Stage | BRK-B | SKWD | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $490M100.00% | BRK-B ×207.97 |
| Gross profit | 54.87%$55.9B | 99.07%$485M | SKWD +44.2pp |
| Operating income | 16.77%$17.1B | 14.78%$72M | BRK-B +2.0pp |
| Pre-tax income | 31.25%$31.8B | 12.98%$64M | BRK-B +18.3pp |
| Net income |
| 25.31%$25.8B |
| 10.02%$49M |
| BRK-B +15.3pp |
None
No disclosed counterparties: BRK-B.